ScholarIQanswers from OpenAlex

Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis

PaperCitations, authors & open-access status

Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis have?

ScholarIQcitation count

Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis has 14 citations in the OpenAlex counts ScholarIQ stores.

When was Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis published?

ScholarIQyear

Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis has 2022 year in the ScholarIQ index.

What is the open-access status of Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis?

ScholarIQoa status

Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis has green oa status in the ScholarIQ index.

What is the DOI of Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis?

ScholarIQdoi

The DOI for Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis is on the source record.

What is the PMID of Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis?

ScholarIQpmid

The PMID for Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis is on the source record.

What is the OpenAlex record for Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis?

ScholarIQopenalex

The OpenAlex for Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial